News
Stelis concludes US$ 195m Series B and Series C fund raise
Stelis Biopharma (Stelis) announced that it has successfully concluded its Series B and Series C fund raise for a cumulative amount of US$ 195m....
News
Peli BioThermal Broadens Portfolio of Dry Ice Shippers
Peli BioThermal, the global name in temperature controlled packaging, announces expanded dry ice shipper options to support exponential growth in cell and gene therapy...
Drug Research
Moderna Announces New Supply Agreement with the Philippines for 7 Million Additional Doses of COVID-19 Vaccine Moderna
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Philippines has secured 7 million additional doses of COVID-19...
News
Roche’s antibody cocktail lowers hospitalisation by 70% in Covid-19 patients
Roche has reported that the Phase III REGN-COV 2067 trial of investigational antibody cocktail of casirivimab and imdevimab met its primary endpoint of reducing...
Clinical Trials
Phase 3 Trial Shows REGEN-COV antibody Cocktail Reduced Hospitalization or Death by 70% in Non-hospitalized COVID-19 Patients
Regeneron Pharmaceuticals, Inc. announced positive topline results from the largest trial to date assessing a COVID-19 treatment in infected non-hospitalized patients (n=4,567). This definitive...
Clinical Trials
BioAge Initiates Phase 2 Trial of BGE-175 to Treat COVID-19 by Reversing Immune Aging
BioAge Labs, Inc., a clinical-stage biotechnology company developing medications that target aging to treat severe diseases, announced that it has commenced a Phase 2...
News
Plus Therapeutics, Piramal Ink Master Services Agreement
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company developing novel, targeted therapies for rare and difficult to treat cancers, announced that it has entered into...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read